Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

Cardiac ablation procedure performed with Stereotaxis System featured on recent BBC documentary

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

Boston Scientific combines Cardiovascular Group and Cardiac Rhythm Management Group

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Atrial fibrillation more common among competition skiers

Atrial fibrillation more common among competition skiers

Endurance athletes at high risk of atrial fibrillation

Endurance athletes at high risk of atrial fibrillation

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

St. Jude Medical's USB cellular adaptor receives European CE Mark approval for Merlin@home transmitter

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

Hospitals use new robotic catheter guidance system to treat abnormal heart rhythms

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

New technique may reduce recovery time in arrhythmia patients

New technique may reduce recovery time in arrhythmia patients

St. Jude Medical to commence enrollment in IRASE AF trial

St. Jude Medical to commence enrollment in IRASE AF trial

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

Daiichi Sankyo initiates Phase III trial of edoxaban in reducing recurrent VTE complications

AtriCure announces definitive agreement with DOJ regarding surgical ablation devices

AtriCure announces definitive agreement with DOJ regarding surgical ablation devices

Lebanon Cardiology Associates and The Good Samaritan Hospital team up to implement hypothermia protocol for improved cardiac care

Lebanon Cardiology Associates and The Good Samaritan Hospital team up to implement hypothermia protocol for improved cardiac care

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

Clinical trial data of Medtronic Arctic Front CryoAblation Catheter System for treating AF to be presented

St. Jude Medical reports net sales of $1.203 billion in fourth-quarter of 2009

St. Jude Medical reports net sales of $1.203 billion in fourth-quarter of 2009

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

AFib: NAVISTAR THERMOCOOL Catheter provides better outcomes compared to drug therapy

Ablation therapy better than drug therapy for heart rhythm disorder

Ablation therapy better than drug therapy for heart rhythm disorder

Abaxis' new CRP assay receives FDA marketing clearance

Abaxis' new CRP assay receives FDA marketing clearance

Special report on A-Fib to be premiered in RLTV's Healthline series

Special report on A-Fib to be premiered in RLTV's Healthline series

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.